Sandoz Head Francis To Leave Amid Move Towards Autonomy
• By Aidan Fry
Sandoz' global head, Richard Francis, is stepping down as Novartis' generics and biosimilars division embarks on a wide-ranging transformation plan • Source: Novartis
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
